Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

18
Number of overlapping holdings
9.4%
% of IBB's 212 holdings also in IBRN
43.9%
% of IBRN's 55 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in IBRN |
Overlap | |
---|---|---|---|---|
ARGENX SE ADR | 3.1% | 4.5% | 3.1% | |
BIOGEN IDEC INC | 2.2% | 3.0% | 2.2% | |
NEUROCRINE BIOSCIENCES INC | 1.3% | 4.3% | 1.3% | |
SAREPTA THERAPEUTICS INC | 1.1% | 3.9% | 1.1% | |
INTRA-CELLULAR THERAPIES INC | 0.8% | 4.6% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IBRN
GILEAD SCIENCES INC | 9.9% | |
VERTEX PHARMACEUTICALS INC | 8.0% | |
AMGEN INC | 6.9% | |
REGENERON PHARMACEUTICALS | 5.3% | |
IQVIA HOLDINGS INC | 3.7% | |
ALNYLAM PHARMACEUTICALS INC | 3.2% | |
METTLER-TOLEDO INTERNATIONAL | 2.7% | |
BIONTECH SE SPONSORED ADR | 2.5% | |
ILLUMINA INC | 2.3% | |
WATERS CORP | 2.3% |
IBB Underweight Relative to IBRN
PTC THERAPEUTICS INC | -5.6% | |
SCHOLAR ROCK HOLDING CORP. | -5.2% | |
CATALYST PHARMACEUTICAL PART | -4.4% | |
ALKERMES PLC | -4.1% | |
ACADIA PHARMACEUTICALS INC | -4.1% | |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% | |
SUPERNUS PHARMACEUTICALS INC | -3.8% | |
INTRA-CELLULAR THERAPIES INC | -3.8% | |
INTEGRA LIFESCIENCES HOLDING | -3.1% | |
EDGEWISE THERAPEUTICS, INC. | -3.1% |